R. Jude Samulski, Ph.D., was honored by the American Society of Gene + Cell Therapy (ASGCT) with its Founders Award at the ...

North Carolina Agricultural and Technical State University will collaborate with another historically Black college and ...

Durham-based BioCryst Pharmaceuticals, a global biotechnology company focused on developing and commercializing medicines for rare diseases, has signed a European licensing agreement for one of its ...

Novartis will add a new North Carolina facility for active pharmaceutical ingredient (API) manufacturing for solid dosage ...

The Alexandria Center for Life Science - Durham North Campus (ACLS-D), at 42 Moore Drive, won the distinction. It’s located ...

Novartis announced a second investment in NC of $220M for a new facility on its Morrisville campus, focused on active pharmaceutical ingredient API manufacturing for solid dosage tablets, capsules, ...

Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

Southeastern North Carolina’s rural Scotland County community of Maxton is getting 10 new jobs as the result of a $1.9 million investment in an expansion at the local Huvepharma factory. The expansion ...

An initiative connecting military talent with job opportunities in North Carolina’s growing biopharmaceutical manufacturing industry will expand, thanks to a new federal grant. The two-year, $825,000 ...

This event facilitates a collaborative environment, where pharma and biotech leaders discuss solutions to current challenges through innovations and partnerships. For additional details, visit the ...

A California medical technology startup plans to expand the Research Triangle Park facility it bought in 2022, adding 50 jobs and spending up to $65 million on the project. Science Corp. in Alameda, ...